Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing
ContributorsLima, John J; Thomas, Cameron D; Barbarino, Julia; Desta, Zeruesenay; Van Driest, Sara L; El Rouby, Nihal; Johnson, Julie A; Cavallari, Larisa H; Shakhnovich, Valentina; Thacker, David L; Scott, Stuart A; Schwab, Matthias; Uppugunduri Satyanarayana, Chakradhara Rao
; Formea, Christine M; Franciosi, James P; Sangkuhl, Katrin; Gaedigk, Andrea; Klein, Teri E; Gammal, Roseann S; Furuta, Takahisa

Published inClinical Pharmacology and Therapeutics
Publication date2020
Abstract
Research group
Funding
- European Commission - UPGx grant 668353
Citation (ISO format)
LIMA, John J et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C19 and Proton Pump Inhibitor Dosing. In: Clinical Pharmacology and Therapeutics, 2020. doi: 10.1002/cpt.2015
Main files (1)
Article (Published version)

Identifiers
- PID : unige:150660
- DOI : 10.1002/cpt.2015
- PMID : 32770672
ISSN of the journal0009-9236